Article
Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution
2021-11-13
Abstract excerpt
Heterogeneity among cancer cells and in the tumor microenvironment (TME) is thought to be a significant contributor to the heterogeneity of clinical therapy response observed between patients and can evolve over time. A primary example of this is multiple myeloma (MM), a generally incurable cancer where such heterogeneity contributes to the persistent evolution of drug resistance. However, there is a paucity of fu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5bd27b57-63eb-55e0-9cfd-7f632708d4d9
- DOI
- 10.1101/2021.11.12.467843
